Company Search:
Advanced Search
Sponsored Links
Avita Medical Limited - ADR Company Snapshot
Avita Medical Limited operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Avita Medical Limited with three other companies in this sector in the United States: Mymetics Corporation (2018 sales of $1.14 million ), Windtree Therapeutics Inc ($1.79 million ), and Vical Incorporated ($1.62 million of which 100% was Biopharmaceutical products).

Sales Analysis. During the year ended June of 2018, sales at Avita Medical Limited were $1.33 million. This is an increase of 35.1% versus 2017, when the company's sales were $983,538.33 . Sales of Operating-Americas. saw an increase of 50.5% in 2018, from $5.19 million to $7.82 million.
  Stock Performance Chart for Avita Medical Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): 5.64
(Figures in U.S. Dollars)
1 Week 6.3%   13 Weeks -7.3%  
4 Weeks -13.0%   52 Weeks 330.2%  
Avita Medical Limited - ADR Key Data:
  Ticker: AVMXY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 1,328,697
(Year Ending Jan 2019).
Employees: 55
  Currency: U.S. Dollars Market Cap: 465,570,840
  Fiscal Yr Ends: June Shares Outstanding: 82,621,267
  Share Type: Common Closely Held Shares: 7,779,815
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.